Brian Conway - Ozop Surgical Chairman CEO
OZSC Stock | USD 0.0008 0.0001 11.11% |
Insider
Brian Conway is Chairman CEO of Ozop Surgical Corp
Age | 51 |
Phone | 845 544 5112 |
Web | https://www.ozopenergy.com |
Ozop Surgical Management Efficiency
The company has return on total asset (ROA) of (0.3767) % which means that it has lost $0.3767 on every $100 spent on assets. This is way below average. Ozop Surgical's management efficiency ratios could be used to measure how well Ozop Surgical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Walter Michalec | Pioneer Power Solutions | 36 | |
Amir Moftakhar | ESS Tech | 47 | |
Dirk Hoefelmann | Plug Power | 56 | |
L Doerr | Bloom Energy Corp | 68 | |
Elaine WeidmanGrunewald | Ads Tec Energy | 57 | |
Betsy Schaefer | FuelCell Energy | N/A | |
Tim Cortes | Plug Power | N/A | |
Shawn Soderberg | Bloom Energy Corp | 62 | |
Azeez Mohammed | Bloom Energy Corp | N/A | |
Will McKenna | Solid Power | N/A | |
Gao Lu | Microvast Holdings | 40 | |
Chris White | Bloom Energy Corp | 56 | |
Melissa Berube | Eos Energy Enterprises | 42 | |
Julia Song | ESS Tech | 45 | |
Sarah Alexander | Microvast Holdings | 40 | |
Are Brautaset | FREYR Battery SA | 53 | |
Pr Lee | Solid Power | N/A | |
Lee Sweigart | FuelCell Energy | 48 | |
Xiangyu Pei | CBAK Energy Technology | 35 | |
Jiewei Thierry | CBAK Energy Technology | 34 | |
Robert Spotnitz | Enovix Corp | N/A |
Management Performance
Return On Asset | -0.38 |
Ozop Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ozop Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.38 | |||
Profit Margin | 0.45 % | |||
Operating Margin | (0.32) % | |||
Current Valuation | 41.18 M | |||
Shares Outstanding | 4.82 B | |||
Price To Earning | 0.60 X | |||
Price To Book | 38.00 X | |||
Price To Sales | 1.37 X | |||
Revenue | 11.93 M | |||
Gross Profit | 1.59 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ozop Pink Sheet
Ozop Surgical financial ratios help investors to determine whether Ozop Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ozop with respect to the benefits of owning Ozop Surgical security.